A

Avoro Capital Advisors (formerly venBio Select Advisor)

15 employees

Avoro Capital Advisors is a global life sciences investment firm.

Investor insights

Sectors invested in

Biotechnology5
Health Care4
Therapeutics3
Medical2
Biopharma2
cancer research1
Life Science1
Medical Device1
oncology1
antibody drug conjugates1
drug development1
bioconjugation1

Funding rounds participated in

$100M sweet spot round size

Most of their 5 investments are in rounds between $65M and $150M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Biotechnology
Financial Services
Therapeutics
Biopharma

Date founded

2010

Investments made

K

Krystal Biotech, Inc. raised $160M on May 21, 2023

Investors: Redmile Group, Braidwell and Avoro Capital Advisors (formerly venBio Select Advisor)

K

Kymera Therapeutics raised $150M on August 19, 2022

Investors: T. Rowe Price, Redmile Group and Avoro Capital Advisors (formerly venBio Select Advisor)

S

Scribe Therapeutics raised $100M on March 31, 2021

Investors: Wellington Management, RA Capital Management, L.P., T. Rowe Price, Andreessen Horowitz, Perceptive Advisors, OrbiMed Advisors, Menlo Ventures and Avoro Capital Advisors (formerly venBio Select Advisor)

P

PMV Pharmaceuticals, Inc. raised $70M on August 3, 2020

Investors: Nextech Invest, OrbiMed Advisors, Viking Global Investors, RA Capital Management, L.P., Wellington Management and Avoro Capital Advisors (formerly venBio Select Advisor)

M

Mersana Therapeutics raised $65M on April 7, 2020

Investors: Consonance Capital and Avoro Capital Advisors (formerly venBio Select Advisor)

FAQ